HLB Pharmaceutical Co., Ltd.
Research HLB Pharmaceutical Co., Ltd. (047920.KQ) on Bullrun: market cap KRW 461.31B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker047920.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 461.31B
- Financial periodQ2 2026
- RevenueKRW 62.28B
- Net income-KRW 56.67M
- Free cash flow-KRW 270.80M
- Gross margin44.0%
Valuation Snapshot
latest market cap is KRW 461.31B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 461.31B | n/a | n/a | n/a |
Dividend history
About HLB Pharmaceutical Co., Ltd.
HLB Pharmaceutical Co., Ltd. researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxant, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids,...
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HLB Pharmaceutical Co., Ltd.'s market cap?
HLB Pharmaceutical Co., Ltd.'s market capitalization is KRW 461.31B.
What does HLB Pharmaceutical Co., Ltd. do?
HLB Pharmaceutical Co., Ltd. researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxant, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dental drugs, multivitamins, parasistic skin disese drugs, dermatlogicals, agents.